These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1177 related items for PubMed ID: 19042026

  • 1. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV, McElroy SL, Harnett-Sheehan K, Keck PE, Janavs J, Rogers J, Gonzalez R, Shivakumar G, Suppes T.
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [Abstract] [Full Text] [Related]

  • 2. Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol.
    Smulevich AB, Khanna S, Eerdekens M, Karcher K, Kramer M, Grossman F.
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):75-84. PubMed ID: 15572276
    [Abstract] [Full Text] [Related]

  • 3. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H, Raassina R, Penttinen J, Ahokas A, Jokinen R, Koponen H, Lepola U, Kanerva H, Lehtonen L, Pohjalainen T, Partanen A, Mäki-Ikola O, Rouru J, Deramciclane Dose-Finding Study Group.
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [Abstract] [Full Text] [Related]

  • 4. A randomized, double-blind, placebo-controlled study of ziprasidone monotherapy in bipolar disorder with co-occurring lifetime panic or generalized anxiety disorder.
    Suppes T, McElroy SL, Sheehan DV, Hidalgo RB, Cosgrove VE, Gwizdowski IS, Feldman NS.
    J Clin Psychiatry; 2014 Jan; 75(1):77-84. PubMed ID: 24345758
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
    Thase ME, Macfadden W, Weisler RH, Chang W, Paulsson B, Khan A, Calabrese JR, BOLDER II Study Group.
    J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817
    [Abstract] [Full Text] [Related]

  • 6. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study.
    Haas M, Delbello MP, Pandina G, Kushner S, Van Hove I, Augustyns I, Quiroz J, Kusumakar V.
    Bipolar Disord; 2009 Nov; 11(7):687-700. PubMed ID: 19839994
    [Abstract] [Full Text] [Related]

  • 7. A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently.
    Macfadden W, Alphs L, Haskins JT, Turner N, Turkoz I, Bossie C, Kujawa M, Mahmoud R.
    Bipolar Disord; 2009 Dec; 11(8):827-39. PubMed ID: 19922552
    [Abstract] [Full Text] [Related]

  • 8. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B.
    Depress Anxiety; 2007 Dec; 24(1):1-14. PubMed ID: 16894619
    [Abstract] [Full Text] [Related]

  • 9. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
    Bose A, Korotzer A, Gommoll C, Li D.
    Depress Anxiety; 2008 Dec; 25(10):854-61. PubMed ID: 18050245
    [Abstract] [Full Text] [Related]

  • 10. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies.
    Pollack MH, Tiller J, Xie F, Trivedi MH.
    J Clin Psychopharmacol; 2008 Jun; 28(3):308-16. PubMed ID: 18480688
    [Abstract] [Full Text] [Related]

  • 11. Acute and continuation risperidone monotherapy in mania.
    Vieta E, Brugué E, Goikolea JM, Sánchez-Moreno J, Reinares M, Comes M, Colom F, Martínez-Arán A, Benabarre A, Torrent C.
    Hum Psychopharmacol; 2004 Jan; 19(1):41-5. PubMed ID: 14716711
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.
    Rynn M, Russell J, Erickson J, Detke MJ, Ball S, Dinkel J, Rickels K, Raskin J.
    Depress Anxiety; 2008 Jan; 25(3):182-9. PubMed ID: 17311303
    [Abstract] [Full Text] [Related]

  • 13. Randomized, placebo-controlled trial of quetiapine XR and divalproex ER monotherapies in the treatment of the anxious bipolar patient.
    Sheehan DV, Harnett-Sheehan K, Hidalgo RB, Janavs J, McElroy SL, Amado D, Suppes T.
    J Affect Disord; 2013 Feb 15; 145(1):83-94. PubMed ID: 22920718
    [Abstract] [Full Text] [Related]

  • 14. Divalproex in the treatment of bipolar depression: a placebo-controlled study.
    Davis LL, Bartolucci A, Petty F.
    J Affect Disord; 2005 Apr 15; 85(3):259-66. PubMed ID: 15780695
    [Abstract] [Full Text] [Related]

  • 15. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study.
    Vieta E, Goikolea JM, Corbella B, Benabarre A, Reinares M, Martínez G, Fernández A, Colom F, Martínez-Arán A, Torrent C, Group for the Study of Risperidone in Affective Disorders (GSRAD).
    J Clin Psychiatry; 2001 Oct 15; 62(10):818-25. PubMed ID: 11816872
    [Abstract] [Full Text] [Related]

  • 16. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH, Dunner DL.
    Depress Anxiety; 2008 Oct 15; 25(2):91-7. PubMed ID: 17311265
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME.
    Arch Gen Psychiatry; 2005 Jan 15; 62(1):37-45. PubMed ID: 15630071
    [Abstract] [Full Text] [Related]

  • 18. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
    DelBello MP, Chang K, Welge JA, Adler CM, Rana M, Howe M, Bryan H, Vogel D, Sampang S, Delgado SV, Sorter M, Strakowski SM.
    Bipolar Disord; 2009 Aug 15; 11(5):483-93. PubMed ID: 19624387
    [Abstract] [Full Text] [Related]

  • 19. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.
    Vieta E, Calabrese JR, Goikolea JM, Raines S, Macfadden W, BOLDER Study Group.
    Bipolar Disord; 2007 Jun 15; 9(4):413-25. PubMed ID: 17547587
    [Abstract] [Full Text] [Related]

  • 20. Adjunctive risperidone in the treatment of generalized anxiety disorder: a double-blind, prospective, placebo-controlled, randomized trial.
    Pandina GJ, Canuso CM, Turkoz I, Kujawa M, Mahmoud RA.
    Psychopharmacol Bull; 2007 Jun 15; 40(3):41-57. PubMed ID: 18007568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.